In our previous studies [15, 16], we found Gal-3 upregulation in PAH patients, and in animal experiments found that Gal-3 mediates right ventricular fibrosis and pulmonary adventitial fibroblast activation. The gene discussed is LGALS3; the disease is pulmonary arterial hypertension.